Propafenone efficacy in paroxysmal atrial fibrillation
Efficacy and safety of class IС antiarrhythmic agent, propafenone, was investigated in patients with paroxysmal atrial fibrillation (PAF), after single-dose load and during long-term preventive treatment. The study included 20 male and female patients (mean age 53,8+2,4 years). PAF was caused by cor...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| Saila: | Российский кардиологический журнал |
| Gaiak: | |
| Sarrera elektronikoa: | https://russjcardiol.elpub.ru/jour/article/view/2328 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|